Immutep Story

<div class='circular--portrait' style='background:#006400;color: #F5FFFA;font-size:3em;'>IMM</div>
IMMP -- USA Stock  

USD 3.37  0.11  3.16%

Immutep Tangible Assets Book Value per Share are very stable at the moment as compared to the past year. Immutep reported last year Tangible Assets Book Value per Share of 0.83. As of 26th of March 2021, Net Cash Flow or Change in Cash and Cash Equivalents is likely to grow to about 9.3 M, while Earnings before Tax are likely to drop (16.7 M). In this article, we will recap Immutep as a potential position in addition to your existing holdings. We will focus on why it could be a game-changer for Immutep insiders.
Published over two weeks ago
View all stories for Immutep | View All Stories
Are Immutep (NASDAQ:IMMP) insiders starting to hold back?
On a scale of 0 to 100, Immutep holds a performance score of 6. The company retains a Market Volatility (i.e. Beta) of -0.525, which attests to possible diversification benefits within a given portfolio. Let's try to break down what Immutep's beta means in this case. As returns on the market increase, returns on owning Immutep are expected to decrease at a much lower rate. During the bear market, Immutep is likely to outperform the market. Although it is vital to follow Immutep Limited current price history, it is good to be conservative about what you can do with the information regarding equity current price movements. The philosophy towards determining future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. We have found twenty-seven technical indicators for Immutep Limited, which you can use to evaluate the performance of the firm. Please utilizes Immutep treynor ratio, as well as the relationship between the semi variance and daily balance of power to make a quick decision on whether Immutep Limited current trending patterns will revert.
There are currently many different techniques concerning forecasting the market as a whole as well as predicting future values of individual securities such as Immutep Limited. Regardless of method or technology, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Predictive Modules for Immutep

Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Immutep's stock price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Immutep in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Immutep. Your research has to be compared to or analyzed against Immutep's peers to derive any actionable benefits. When done correctly, Immutep's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Immutep Limited.

How important is Immutep's Liquidity

Immutep financial leverage refers to using borrowed capital as a funding source to finance Immutep Limited ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Immutep financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Immutep's total debt and its cash.

How Immutep utilizes its cash?

To perform a cash flow analysis of Immutep, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Immutep is receiving and how much cash it distributes out in a given period. The Immutep cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Immutep Net Cash Flow from Operations is very stable at the moment as compared to the past year. Immutep reported last year Net Cash Flow from Operations of (12.47 Million)

Breaking it down

Immutep Limited exhibits very low volatility with skewness of 0.24 and kurtosis of 0.35. However, we advise investors to further study Immutep Limited technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Immutep's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Immutep's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Returns Breakdown

Return on Assets(0.38)
Return on Equity(0.45)
Return Capital(1.29)
Return on Sales(1.02)

Are Immutep technical ratios showing a correction?

The value at risk is down to -6.06 as of today. Immutep Limited exhibits very low volatility with skewness of 0.24 and kurtosis of 0.35. However, we advise investors to further study Immutep Limited technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Immutep's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Immutep's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

The Current Takeaway on Immutep Investment

Although some other companies under the biotechnology industry are still a bit expensive, Immutep may offer a potential longer-term growth to insiders. To conclude, as of the 26th of March 2021, we believe that Immutep is currently undervalued with below average chance of financial distress in the next two years. However, our actual 30 days buy-hold-sell advice on the firm is Strong Sell.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Immutep Limited. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com